MARKET

NLTX

NLTX

Neoleukin Therapeutics
NASDAQ

Real-time Quotes | Nasdaq Last Sale

3.670
+0.130
+3.67%
After Hours: 3.670 0 0.00% 16:00 09/18 EDT
OPEN
3.520
PREV CLOSE
3.540
HIGH
3.690
LOW
3.520
VOLUME
76.92K
TURNOVER
--
52 WEEK HIGH
4.230
52 WEEK LOW
2.000
MARKET CAP
140.64M
P/E (TTM)
-3.9105
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of NLTX and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

NLTX News

  • 33 Stocks Moving in Thursday's Pre-Market Session
  • Benzinga.6d ago
  • Neoleukin Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
  • GlobeNewswire.09/05 20:05
  • 66 Biggest Movers From Yesterday
  • Benzinga.09/04 09:07
  • 70 Biggest Movers From Yesterday
  • Benzinga.08/30 08:05

More

Industry

Biotechnology & Medical Research
-0.68%
Pharmaceuticals & Medical Research
-0.14%

Hot Stocks

Name
Price
%Change

About NLTX

Neoleukin Therapeutics, Inc., formerly Aquinox Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is focused on the development and commercialization of computationally-designed protein therapeutics to address unmet medical needs in immuno-oncology, inflammation, and autoimmunity. Its computational platform allows it to design new de novo proteins to treat serious diseases, including cancer, inflammatory, and autoimmune disorders. Its lead program, NL-201, is a computationally-designed de novo protein therapeutic. NL-201 is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. NL-201 is designed for use as a single-agent or in combination with complementary therapeutic modalities.
More

Webull offers Neoleukin Therapeutics Inc (NLTX) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.